The Mekong Delta’s pangasius industry is a critical pillar of Vietnam’s aquaculture sector, yet its long-term sustainability is increasingly challenged by disease pressures, inconsistent biosecurity, limited access to modern technologies, and persistent dependence on chemicals and antibiotics.
The DeltaVax project addresses these constraints through an integrated, multi-partner initiative designed to strengthen fish health management, enhance diagnostic capacity, and expand the adoption of proven vaccination and water-quality technologies across the region.
Implemented by a consortium of Vietnamese, Dutch, and international partners including Fresh Studio, PHARMAQ part of Zoetis, Can Tho University, De Heus, and Kytos, the project combines applied research, farmer training, and technology demonstration at scale.
DeltaVax delivers three core interventions:
A sector-wide baseline survey provides evidence for assessing environmental impacts, disease prevalence, and farmer practices, while RAS demonstrations introduce modern production concepts to the region.
Expected outcomes include improved fish health and survival, reduced antibiotic and chemical use, strengthened local service sectors (such as diagnostics and water_quality management), and enhanced food safety and product quality for domestic and export markets.
By modernizing technical capacity and catalysing technology uptake, DeltaVax aims to accelerate the transition toward a more resilient, knowledge_driven, and environmentally responsible pangasius value chain.